[1]
2022. Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b/3, Double-Blind, Placebo-Controlled Study. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s103. DOI:https://doi.org/10.25251/skin.6.supp.103.